The latest national survey from Chronic Pain Australia found that more than a third of respondents said, after discussing medicinal cannabis as a pain treatment with their GP that they faced difficulty when it came around to the approval process. Read the article here.
ANTG’s James Gaskell joins 2SER Breakfast on 107.3 to discuss his thoughts on ACT’s recent legalisation of cannabis, the conflict of state vs federal laws, and the medicinal cannabis industry in Australia and abroad.
In the first 12 months we expect to see two tonnes plus in export. Exportation will begin to Germany, where we have signed a 10-year supply contract with Cannamedical Pharma.
A report into the Narcotic Drugs Act (ND Act) has recommended several changes to medical cannabis regulation in Australia.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >